Reaserch Advances in Immunotherapy for Acute Myeloid Leukemia--Review].

Ze-Hui Chen, Yue-Yang Li, Chen Tian

Zhongguo shi yan xue ye xue za zhi 2020 Dec

filter terms:

Acute myeloid leukemia (AML) is a malignant tumor with abnormal myelocyte differentiation. With the development of immunological technology, great importance has been attached to the immunotherapy of AML patients, which may become an effective treatment strategy for AML, and providing a new means for the prognosis and survival. In this review, the advanced research of immunotherapy for AML, such as antibody-dependent drugs, chimeric antigen receptor T cell therapy, and checkpoint inhibitors, the bastest reaserch advanves of clinical experiment for immunotherapy was summarized briefly.

Citation

Ze-Hui Chen, Yue-Yang Li, Chen Tian. Reaserch Advances in Immunotherapy for Acute Myeloid Leukemia--Review]. Zhongguo shi yan xue ye xue za zhi. 2020 Dec;28(6):2089-2092